Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: systematic review and meta-analysis

JJ McCabe, E O'reilly, S Coveney… - European stroke …, 2021 - journals.sagepub.com
Background Recent randomised trials showed benefit for anti-inflammatory therapies in
coronary disease but excluded stroke. The prognostic value of blood inflammatory markers …

Copeptin: up-to-date diagnostic and prognostic role highlight

M Abdelmageed, F Güzelgül - Analytical Biochemistry, 2023 - Elsevier
Arginine Vasopressin (AVP) is one of the key hormones in the human body. AVP is clinically
important because it maintains body fluid balance and vascular tone. Unfortunately, AVP …

C-Reactive Protein, Interleukin-6, and Vascular Recurrence According to Stroke Subtype: An Individual Participant Data Meta-Analysis

JJ McCabe, C Walsh, S Gorey, K Harris, P Hervella… - Neurology, 2024 - AAN Enterprises
Background and Objectives Anti-inflammatory therapies reduce major adverse
cardiovascular events (MACE) in coronary artery disease but remain unproven after stroke …

[HTML][HTML] The role of arginine-vasopressin in stroke and the potential use of arginine-vasopressin type 1 receptor antagonists in stroke therapy: A narrative review

K Chojnowski, M Opiełka, J Gozdalski… - International Journal of …, 2023 - mdpi.com
Stroke is a life-threatening condition in which accurate diagnoses and timely treatment are
critical for successful neurological recovery. The current acute treatment strategies …

Basal IL‐6 and S100b levels are associated with infarct volume

F Purroy, J Farré‐Rodriguez… - Acta Neurologica …, 2021 - Wiley Online Library
Objectives The study of biomarkers related to the infarct volume of acute ischaemic stroke
(AIS) is a valuable clinical strategy. We conducted a prospective study to evaluate the …

Copeptin as a biomarker for prediction of prognosis of acute ischemic stroke and transient ischemic attack: a meta-analysis

Q Xu, Y Tian, H Peng, H Li - Hypertension Research, 2017 - nature.com
This meta-analysis aimed to investigate the predictive effect of copeptin as a biomarker for
the prognosis of acute ischemic stroke and transient ischemic attack. Electronic databases …

Copeptin implementation on stroke prognosis

S Karatzetzou, D Tsiptsios, A Sousanidou… - Neurology …, 2023 - mdpi.com
Predicting functional outcome following stroke is considered to be of key importance in an
attempt to optimize overall stroke care. Although clinical prognostic tools have been widely …

The diagnostic and prognostic value of copeptin in patients with acute ischemic stroke and transient ischemic attack: A systematic review and meta-analysis

N Blek, P Szwed, P Putowska, A Nowicka… - Cardiology …, 2022 - journals.viamedica.pl
Background: Stroke is the second main cause of mortality and the third leading cause of
mortality and permanent disability combined. Many potential biomarkers have been …

Diagnostic and prognostic blood biomarkers in transient ischemic attack and minor ischemic stroke: an up-to-date narrative review

M Foschi, M Padroni, S Abu-Rumeileh… - Journal of Stroke and …, 2022 - Elsevier
Introduction Early diagnosis and correct risk stratification in patients with transient ischemic
attack (TIA) and minor ischemic stroke (MIS) is crucial for the high rate of subsequent …

Biomarkers for transient ischemic attack: a brief perspective of current reports and future horizons

M Nouri-Vaskeh, N Khalili, A Sadighi… - Journal of Clinical …, 2022 - mdpi.com
Cerebrovascular disease is the leading cause of long-term disability in the world and the
third-leading cause of death in the United States. The early diagnosis of transient ischemic …